DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Hassel JC, Heinzerling L, Aberle J. et al.
Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions.
Cancer Treat Rev 2017;
57: 36-49.
DOI: 10.1016/j.ctrv.2017.05.003.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.